Skip to content
Home/Companies/Life Science Tools & Biologic Services/ExcellGene
ExcellGene

ExcellGene

Life Science Tools & Biologic Services·Switzerland·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns ExcellGene?

ExcellGene is currently owned by ARCHIMED through MED Rise (2024 vintage), since 2025.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED Rise · 2024 · Buyout

Key facts

HQSwitzerland
SectorLife Science Tools & Biologic Services
Websiteexcellgene.com

More from MED Rise

Other portfolio companies in the same fund.

IRAB
IRAB
Active
PharmaSpain· 2026
Arkstone
Active
HealthTechUS· 2025
Ceva Animal Health
Ceva Animal Health
Active
HealthcareFrance· 2025
Groupe Laboratoire Rivadis
Active
HealthTechFrance· 2025
ZimVie
ZimVie
Active
MedTechUS· 2025
Biodextris
Active
BiotechCanada· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track ExcellGene

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on ExcellGene.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue